Skye Bioscience Inc (SKYE)

[dragonslayer400]

Basically went up 200% in about a month. Pullback was necessary, needs to take a breather and reset the RSI. Bounced perfectly off the 20 MA. Although it is a volatile ticker and anything can happen, still see the long term trend being up and much higher from these levels. From their recent presentation, they have a number of milestones and PR's coming this year still. Accumulation is also very high still.


Conduct NB1111 neuroprotection of RGC study
• Complete Glauconix glaucoma biomarker study
• Hold FDA PIND meeting
• Open Emerald Bioscience Australia office
• Formulate NB1111 for human use
• Initiate CBDVHS API synthesis
• Initiate CBDVHS ocular animal studies

Announce Australian CRO for human study
• Target Q3-Q4’19 for FPI glaucoma study
• Initiate pre-clinical testing CBDVHS ocular